Goldman Sachs Group Inc. has filed a Free Writing Prospectus (FWP) on November 13, 2026, detailing a new structured investment opportunity. This filing is significant as it showcases the firm's commitment to expanding its investment offerings, particularly in the competitive landscape of security brokers, dealers, and flotation companies.
Goldman Sachs, identified by the Central Index Key (CIK) 0000886982, operates within the SIC classification of 6211, focusing on security brokers, dealers, and flotation companies. The firm is publicly traded on multiple exchanges, including the New York Stock Exchange under the ticker GS, and has a fiscal year ending on December 31. Recent filings include a series of Schedule 13G forms and several 424B2 forms, all filed on the same date as the FWP.
The FWP outlines a structured investment product known as "Contingent Income Auto-Callable Securities," which are based on the performance of major U.S. and international equity indices, including the S&P 500, Russell 2000, and Nasdaq-100. These securities are unsecured notes issued by GS Finance Corp. and guaranteed by Goldman Sachs Group, Inc. The filing indicates that these securities will be due on November 24, 2028, with an expected pricing date around November 20, 2026.
This new investment product may affect a wide range of stakeholders, including investors seeking innovative financial products and competitors in the securities industry. As Goldman Sachs continues to innovate and diversify its offerings, it may prompt other firms to enhance their product lines to remain competitive.
Details regarding the next steps following this filing were not specified in the document. Investors and market participants will be closely monitoring Goldman Sachs' future actions as it rolls out this structured investment opportunity.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










